The U.S. Food and Drug ... (PTSD), according to Lykos Therapeutics, the company that applied for approval. The treatment is a ...

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

During one study, physicians at Walter Reed plan to give the psychedelic drug MDMA to active-duty soldiers with mild to ...

Multidisciplinary Association for Psychedelic Studies (MAPS), the FDA has agreed study designs for two phase 3 studies assessing MDMA-assisted psychotherapy for patients with severe PTSD.

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and ... application for the first psychedelic drug to reach federal regulators was expected ...

As dawn approached on the morning of 7 October 2023, many of the partygoers at the Nova music festival near Gaza's border ...

Emory is poised to expand its research on how MDMA, a psychedelic drug commonly known as ecstasy, could help patients with PTSD when coupled with psychotherapy.

Australia’s first clinical practice guideline on the appropriate use of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) to treat post-traumatic stress disorder (PTSD) is a step closer ...

The preliminary results, currently being peer-reviewed with a view to publication in the coming months, suggest that the drug ... MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder ...